- Home
- TRSG vs TPST Comparison
TRSG vs TPST Comparison
Compare TRSG & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- TPST
- Stock Information
- Founded
- TRSG 1996
- TPST 2011
- Country
- TRSG Singapore
- TPST United States
- Employees
- TRSG N/A
- TPST N/A
- Industry
- TRSG
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- TPST Health Care
- Exchange
- TRSG NYSE
- TPST Nasdaq
- Market Cap
- TRSG 27.0M
- TPST 33.0M
- IPO Year
- TRSG 2024
- TPST N/A
- Fundamental
- Price
- TRSG $1.68
- TPST $6.95
- Analyst Decision
- TRSG
- TPST Hold
- Analyst Count
- TRSG 0
- TPST 3
- Target Price
- TRSG N/A
- TPST $30.00
- AVG Volume (30 Days)
- TRSG 5.6K
- TPST 90.3K
- Earning Date
- TRSG 05-14-2025
- TPST 08-07-2025
- Dividend Yield
- TRSG N/A
- TPST N/A
- EPS Growth
- TRSG N/A
- TPST N/A
- EPS
- TRSG N/A
- TPST N/A
- Revenue
- TRSG $12,810,249.00
- TPST N/A
- Revenue This Year
- TRSG N/A
- TPST N/A
- Revenue Next Year
- TRSG N/A
- TPST N/A
- P/E Ratio
- TRSG N/A
- TPST N/A
- Revenue Growth
- TRSG N/A
- TPST N/A
- 52 Week Low
- TRSG $1.00
- TPST $5.35
- 52 Week High
- TRSG $4.57
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- TPST 46.97
- Support Level
- TRSG N/A
- TPST $7.06
- Resistance Level
- TRSG N/A
- TPST $7.64
- Average True Range (ATR)
- TRSG 0.00
- TPST 0.27
- MACD
- TRSG 0.00
- TPST 0.02
- Stochastic Oscillator
- TRSG 0.00
- TPST 31.91
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.